252 related articles for article (PubMed ID: 34700172)
21. Importance of correctly interpreting magnetic resonance imaging to diagnose posterior reversible encephalopathy syndrome associated with HELLP syndrome: a case report.
Tetsuka S; Nonaka H
BMC Med Imaging; 2017 May; 17(1):35. PubMed ID: 28545408
[TBL] [Abstract][Full Text] [Related]
22. Posterior Reversible Encephalopathy Syndrome in a Patient With SARS-CoV-2 Infection Treated With Tocilizumab.
Talluri K; Lall N; Moreno MA; Nichols L; Bande D
Cureus; 2021 Feb; 13(2):e13475. PubMed ID: 33777563
[TBL] [Abstract][Full Text] [Related]
23. Posterior Reversible Encephalopathy Syndrome in Clinical Toxicology: A Systematic Review of Published Case Reports.
Largeau B; Boels D; Victorri-Vigneau C; Cohen C; Salmon Gandonnière C; Ehrmann S
Front Neurol; 2019; 10():1420. PubMed ID: 32116991
[No Abstract] [Full Text] [Related]
24. Posterior Reversible Encephalopathy Syndrome in Patients With Cancer.
Singer S; Grommes C; Reiner AS; Rosenblum MK; DeAngelis LM
Oncologist; 2015 Jul; 20(7):806-11. PubMed ID: 26032137
[TBL] [Abstract][Full Text] [Related]
25. COVID-19-Associated PRES-like Encephalopathy with Perivascular Gadolinium Enhancement.
Conte G; Avignone S; Carbonara M; Meneri M; Ortolano F; Cinnante C; Triulzi F
AJNR Am J Neuroradiol; 2020 Dec; 41(12):2206-2208. PubMed ID: 32816769
[TBL] [Abstract][Full Text] [Related]
26. Neurological symptoms, manifestations, and complications associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease 19 (COVID-19).
Harapan BN; Yoo HJ
J Neurol; 2021 Sep; 268(9):3059-3071. PubMed ID: 33486564
[TBL] [Abstract][Full Text] [Related]
27. Posterior reversible leukoencephalopathy syndrome (PRES) associated with severe eclampsia: Clinical and biochemical features.
Camara-Lemarroy CR; Escobedo-Zúñiga N; Villarreal-Garza E; García-Valadez E; Góngora-Rivera F; Villarreal-Velázquez HJ
Pregnancy Hypertens; 2017 Jan; 7():44-49. PubMed ID: 28279447
[TBL] [Abstract][Full Text] [Related]
28. A broad spectrum of posterior reversible encephalopathy syndrome - a case series with clinical and paraclinical characterisation, and histopathological findings.
Ismail FS; van de Nes J; Kleffner I
BMC Neurol; 2021 Oct; 21(1):386. PubMed ID: 34615476
[TBL] [Abstract][Full Text] [Related]
29. The imaging spectrum of posterior reversible encephalopathy syndrome: A pictorial review.
Brady E; Parikh NS; Navi BB; Gupta A; Schweitzer AD
Clin Imaging; 2018; 47():80-89. PubMed ID: 28910681
[TBL] [Abstract][Full Text] [Related]
30. Can clinical and MRI findings predict the prognosis of variant and classical type of posterior reversible encephalopathy syndrome (PRES)?
Moon SN; Jeon SJ; Choi SS; Song CJ; Chung GH; Yu IK; Kim DH
Acta Radiol; 2013 Dec; 54(10):1182-90. PubMed ID: 23858507
[TBL] [Abstract][Full Text] [Related]
31. Posterior reversible encephalopathy syndrome (PRES): Is DWI a prognosis factor?
Marrone LCP; Martins WA; Ramos SWMI; Tomasi GH; Garcia MS; Marrone BF; Gadonski G; Poli-de-Figueiredo CE; da Costa BEP; Soder RB; Huf Marrone AC; da Costa JC
J Clin Neurosci; 2020 Feb; 72():357-359. PubMed ID: 31874813
[TBL] [Abstract][Full Text] [Related]
32. The association of posterior reversible encephalopathy syndrome with COVID-19: A systematic review.
Iftikhar S; Rehman AU; Ameer MZ; Nawaz A; Aemaz Ur Rehman M; Farooq H; Asmar A; Ebaad Ur Rehman M
Ann Med Surg (Lond); 2021 Dec; 72():103080. PubMed ID: 34840779
[TBL] [Abstract][Full Text] [Related]
33. Persistent Cortical Blindness Following Posterior Reversible Encephalopathy Syndrome (PRES) as a Complication of COVID-19 Pneumonia.
Elhassan M; Saidahmed O; Adebayo A; Archibald N
Cureus; 2021 Jan; 13(1):e12794. PubMed ID: 33500867
[TBL] [Abstract][Full Text] [Related]
34. Posterior reversible encephalopathy syndrome in cancer patients: a single institution retrospective study.
Kamiya-Matsuoka C; Paker AM; Chi L; Youssef A; Tummala S; Loghin ME
J Neurooncol; 2016 May; 128(1):75-84. PubMed ID: 26900076
[TBL] [Abstract][Full Text] [Related]
35. Acute radiological pattern and outcome in posterior reversible encephalopathy syndrome patients.
Pilato F; Calandrelli R; Distefano M; Panfili M; Della Marca G; Colosimo C
Clin Neurol Neurosurg; 2019 Oct; 185():105459. PubMed ID: 31445327
[TBL] [Abstract][Full Text] [Related]
36. Posterior reversible encephalopathy syndrome (PRES): a rare condition after resection of posterior fossa tumors: two new cases and review of the literature.
González Quarante LH; Mena-Bernal JH; Martín BP; Ramírez Carrasco M; Muñoz Casado MJ; Martínez de Aragón A; de las Heras RS
Childs Nerv Syst; 2016 May; 32(5):857-63. PubMed ID: 26584552
[TBL] [Abstract][Full Text] [Related]
37. Posterior Reversible Encephalopathy Syndrome in a Pediatric COVID-19 Patient.
Korkmazer B; Ozogul M; Hikmat E; Kilic H; Aygun F; Arslan S; Kizilkilic O; Kocer N
Pediatr Infect Dis J; 2021 Jun; 40(6):e240-e242. PubMed ID: 33742613
[TBL] [Abstract][Full Text] [Related]
38. Posterior reversible encephalopathy syndrome: do predisposing risk factors make a difference in MRI appearance?
Mueller-Mang C; Mang T; Pirker A; Klein K; Prchla C; Prayer D
Neuroradiology; 2009 Jun; 51(6):373-83. PubMed ID: 19234694
[TBL] [Abstract][Full Text] [Related]
39. Posterior reversible encephalopathy syndrome with extensive cytotoxic edema after blood transfusion: a case report and literature review.
Nakamura Y; Sugino M; Tsukahara A; Nakazawa H; Yamamoto N; Arawaka S
BMC Neurol; 2018 Nov; 18(1):190. PubMed ID: 30419835
[TBL] [Abstract][Full Text] [Related]
40. Childhood posterior reversible encephalopathy syndrome: Magnetic resonance imaging findings with emphasis on increased leptomeningeal FLAIR signal.
Agarwal A; Kapur G; Altinok D
Neuroradiol J; 2015 Dec; 28(6):638-43. PubMed ID: 26515749
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
